These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| New York | 13-1432060 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) |
| Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o |
| September 30, | December 31, | |||||||
| 2010 | 2009 | |||||||
|
ASSETS
|
||||||||
|
Current Assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 114,885 | $ | 80,135 | ||||
|
Trade receivables
|
519,378 | 454,528 | ||||||
|
Allowance for doubtful accounts
|
(7,405 | ) | (10,263 | ) | ||||
|
Inventories:
|
||||||||
|
Raw materials
|
267,479 | 228,999 | ||||||
|
Work in process
|
8,951 | 9,173 | ||||||
|
Finished goods
|
227,561 | 206,805 | ||||||
|
|
||||||||
|
Total Inventories
|
503,991 | 444,977 | ||||||
|
Deferred income taxes
|
74,699 | 55,002 | ||||||
|
Prepaid expenses and other current assets
|
122,602 | 103,687 | ||||||
|
|
||||||||
|
Total Current Assets
|
1,328,150 | 1,128,066 | ||||||
|
|
||||||||
|
Property, plant and equipment, at cost
|
1,323,900 | 1,265,885 | ||||||
|
Accumulated depreciation
|
(818,227 | ) | (764,592 | ) | ||||
|
|
||||||||
|
|
505,673 | 501,293 | ||||||
|
|
||||||||
|
Goodwill
|
665,582 | 665,582 | ||||||
|
Intangible assets, net
|
50,352 | 54,948 | ||||||
|
Deferred income taxes
|
140,441 | 129,720 | ||||||
|
Other assets
|
174,109 | 165,165 | ||||||
|
|
||||||||
|
Total Assets
|
$ | 2,864,307 | $ | 2,644,774 | ||||
|
|
||||||||
|
|
||||||||
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
||||||||
|
Current Liabilities:
|
||||||||
|
Bank borrowings and overdrafts and current portion of long-term debt
|
$ | 137,872 | $ | 76,780 | ||||
|
Accounts payable
|
169,652 | 161,027 | ||||||
|
Accrued payroll and bonus
|
84,168 | 49,022 | ||||||
|
Accrued taxes on income
|
42,597 | 1,913 | ||||||
|
Dividends payable
|
21,576 | 19,786 | ||||||
|
Restructuring and other charges
|
5,839 | 18,914 | ||||||
|
Other current liabilities
|
181,893 | 157,012 | ||||||
|
|
||||||||
|
Total Current Liabilities
|
643,597 | 484,454 | ||||||
|
|
||||||||
|
|
||||||||
|
Other Liabilities:
|
||||||||
|
Long-term debt
|
810,719 | 934,749 | ||||||
|
Deferred gains
|
51,710 | 54,884 | ||||||
|
Retirement liabilities
|
242,744 | 240,950 | ||||||
|
Other liabilities
|
164,665 | 157,827 | ||||||
|
|
||||||||
|
Total Other Liabilities
|
1,269,838 | 1,388,410 | ||||||
|
|
||||||||
|
|
||||||||
|
Commitments and Contingencies (Note 13)
|
||||||||
|
|
||||||||
|
Shareholders Equity:
|
||||||||
|
Common stock 12 1/2¢ par value; authorized 500,000,000 shares; issued 115,761,840
shares as of September 30, 2010 and December 31, 2009; and outstanding
79,923,153 and 79,157,393 shares as of September 30, 2010 and December 31, 2009
|
14,470 | 14,470 | ||||||
|
Capital in excess of par value
|
106,726 | 110,374 | ||||||
|
Retained earnings
|
2,485,785 | 2,339,205 | ||||||
|
Accumulated other comprehensive loss
|
(265,374 | ) | (270,974 | ) | ||||
|
Treasury stock, at cost 35,838,687 shares as of September 30, 2010 and 36,604,447
shares as of December 31, 2009
|
(1,394,453 | ) | (1,424,072 | ) | ||||
|
|
||||||||
|
Total Shareholders Equity
|
947,154 | 769,003 | ||||||
|
|
||||||||
|
Noncontrolling interest
|
3,718 | 2,907 | ||||||
|
|
||||||||
|
Total Shareholders Equity including noncontrolling interest
|
950,872 | 771,910 | ||||||
|
|
||||||||
|
Total Liabilities and Shareholders Equity
|
$ | 2,864,307 | $ | 2,644,774 | ||||
|
|
||||||||
2
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Net sales
|
$ | 673,283 | $ | 612,634 | $ | 1,992,993 | $ | 1,740,525 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Cost of goods sold
|
388,235 | 363,780 | 1,152,737 | 1,041,692 | ||||||||||||
|
Research and development expenses
|
53,214 | 49,392 | 161,688 | 140,971 | ||||||||||||
|
Selling and administrative expenses
|
108,955 | 101,199 | 336,487 | 290,116 | ||||||||||||
|
Restructuring and other charges
|
2,355 | 10,500 | 9,186 | 14,604 | ||||||||||||
|
Interest expense
|
12,244 | 13,503 | 37,031 | 47,331 | ||||||||||||
|
Other expense (income), net
|
2,097 | (24 | ) | 6,967 | 383 | |||||||||||
|
|
||||||||||||||||
|
|
567,100 | 538,350 | 1,704,096 | 1,535,097 | ||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
106,183 | 74,284 | 288,897 | 205,428 | ||||||||||||
|
Taxes on income
|
29,145 | 21,484 | 80,917 | 57,350 | ||||||||||||
|
|
||||||||||||||||
|
Net income
|
77,038 | 52,800 | 207,980 | 148,078 | ||||||||||||
|
|
||||||||||||||||
|
Other comprehensive income:
|
||||||||||||||||
|
Foreign currency translation adjustments
|
42,055 | 5,161 | 5,412 | 72,595 | ||||||||||||
|
Gains (losses) on derivatives
qualifying as hedges
|
(5,848 | ) | (853 | ) | (5,288 | ) | 343 | |||||||||
|
Pension and postretirement net liability
adjustment
|
2,025 | 1,446 | 5,476 | 3,721 | ||||||||||||
|
|
||||||||||||||||
|
Comprehensive income
|
$ | 115,270 | $ | 58,554 | $ | 213,580 | $ | 224,737 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net income per share basic
|
$ | 0.96 | $ | 0.67 | $ | 2.61 | $ | 1.88 | ||||||||
|
|
||||||||||||||||
|
Net income per share diluted
|
$ | 0.95 | $ | 0.66 | $ | 2.58 | $ | 1.86 | ||||||||
|
|
||||||||||||||||
|
Average number of shares outstanding basic
|
79,357 | 78,491 | 79,078 | 78,346 | ||||||||||||
|
|
||||||||||||||||
|
Average number of shares outstanding diluted
|
80,266 | 79,159 | 79,997 | 78,986 | ||||||||||||
|
|
||||||||||||||||
|
Dividends declared per share
|
$ | 0.27 | $ | 0.25 | $ | 0.77 | $ | 0.75 | ||||||||
3
| Nine Months Ended September 30, | ||||||||
| 2010 | 2009 | |||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$ | 207,980 | $ | 148,078 | ||||
|
Adjustments to reconcile to net cash provided by operations:
|
||||||||
|
Depreciation and amortization
|
60,137 | 58,074 | ||||||
|
Deferred income taxes
|
(40,720 | ) | 2,421 | |||||
|
Gain on disposal of assets
|
(2,960 | ) | (2,366 | ) | ||||
|
Equity based compensation
|
16,708 | 15,065 | ||||||
|
Changes in assets and liabilities:
|
||||||||
|
Current receivables
|
(60,926 | ) | (56,280 | ) | ||||
|
Inventories
|
(53,155 | ) | 61,310 | |||||
|
Current payables
|
92,841 | 15,647 | ||||||
|
Other assets
|
(22,224 | ) | (40,219 | ) | ||||
|
Other liabilities
|
10,644 | (1,658 | ) | |||||
|
|
||||||||
|
Net cash provided by operations
|
208,325 | 200,072 | ||||||
|
|
||||||||
|
Cash flows from investing activities:
|
||||||||
|
Additions to property, plant and equipment
|
(53,597 | ) | (29,755 | ) | ||||
|
Purchase of investments
|
(3,592 | ) | (3,288 | ) | ||||
|
Termination / maturity of net investment hedges
|
1,668 | (13,604 | ) | |||||
|
Proceeds from disposal of assets
|
1,541 | 1,192 | ||||||
|
|
||||||||
|
Net cash used in investing activities
|
(53,980 | ) | (45,455 | ) | ||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Cash dividends paid to shareholders
|
(59,605 | ) | (78,441 | ) | ||||
|
Net change in bank borrowings and overdrafts
|
(76,086 | ) | (48,318 | ) | ||||
|
Repayments of long-term debt
|
| (52,800 | ) | |||||
|
Proceeds from issuance of stock under stock-based
compensation plans
|
17,105 | 2,103 | ||||||
|
Purchase of treasury stock
|
| (1,967 | ) | |||||
|
|
||||||||
|
Net cash used in financing activities
|
(118,586 | ) | (179,423 | ) | ||||
|
|
||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(1,009 | ) | 911 | |||||
|
|
||||||||
|
Net change in cash and cash equivalents
|
34,750 | (23,895 | ) | |||||
|
Cash and cash equivalents at beginning of year
|
80,135 | 178,467 | ||||||
|
|
||||||||
|
Cash and cash equivalents at end of period
|
$ | 114,885 | $ | 154,572 | ||||
|
|
||||||||
|
|
||||||||
|
Interest paid
|
$ | 53,086 | $ | 69,243 | ||||
|
|
||||||||
|
Income taxes paid
|
$ | 45,882 | $ | 40,037 | ||||
4
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| (Shares in thousands) | 2010 | 2009 | 2010 | 2009 | ||||||||||||
|
Basic
|
79,357 | 78,491 | 79,078 | 78,346 | ||||||||||||
|
Assumed dilution under stock plans
|
909 | 668 | 919 | 640 | ||||||||||||
|
|
||||||||||||||||
|
Diluted
|
80,266 | 79,159 | 79,997 | 78,986 | ||||||||||||
|
|
||||||||||||||||
5
| Asset- | ||||||||||||
| Employee- | Related | |||||||||||
| Related | and Other | Total | ||||||||||
|
Balance December 31, 2009
|
$ | 18,914 | $ | | $ | 18,914 | ||||||
|
Additional charges
|
4,938 | 4,248 | 9,186 | |||||||||
|
Payments and other costs
|
(18,013 | ) | (1,341 | ) | (19,354 | ) | ||||||
|
Non-cash charges
|
| (2,907 | ) | (2,907 | ) | |||||||
|
|
||||||||||||
|
Balance September 30, 2010
|
$ | 5,839 | $ | | $ | 5,839 | ||||||
|
|
||||||||||||
| (DOLLARS IN THOUSANDS) | Amount | |||
|
Flavors
|
$ | 319,479 | ||
|
Fragrances
|
346,103 | |||
|
|
||||
|
Total
|
$ | 665,582 | ||
|
|
||||
6
| September 30, | December 31, | |||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | ||||||
|
Gross carrying value
|
$ | 165,406 | $ | 165,406 | ||||
|
Accumulated amortization
|
(115,054 | ) | (110,458 | ) | ||||
|
|
||||||||
|
Total
|
$ | 50,352 | $ | 54,948 | ||||
|
|
||||||||
| Accumulated (losses) | Pension and | |||||||||||||||
| gains on derivatives | postretirement net | |||||||||||||||
| Translation | qualifying as hedges, | liability adjustment, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | adjustments | net of tax | net of tax | Total | ||||||||||||
|
Balance December 31, 2009
|
$ | (68,606 | ) | $ | (2,741 | ) | $ | (199,627 | ) | $ | (270,974 | ) | ||||
|
Change
|
5,412 | (5,288 | ) | 5,476 | 5,600 | |||||||||||
|
|
||||||||||||||||
|
Balance September 30, 2010
|
$ | (63,194 | ) | $ | (8,029 | ) | $ | (194,151 | ) | $ | (265,374 | ) | ||||
|
|
||||||||||||||||
| Accumulated (losses) | Pension and | |||||||||||||||
| gains on derivatives | postretirement net | |||||||||||||||
| Translation | qualifying as hedges, | liability adjustment, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | adjustments | net of tax | net of tax | Total | ||||||||||||
|
Balance December 31, 2008
|
$ | (149,846 | ) | $ | (3,832 | ) | $ | (171,427 | ) | $ | (325,105 | ) | ||||
|
Change
|
72,595 | 343 | 3,721 | 76,659 | ||||||||||||
|
|
||||||||||||||||
|
Balance September 30, 2009
|
$ | (77,251 | ) | $ | (3,489 | ) | $ | (167,706 | ) | $ | (248,446 | ) | ||||
|
|
||||||||||||||||
7
| (DOLLARS IN THOUSANDS) | Rate | Maturities | September 30, 2010 | December 31, 2009 | ||||||||||||
|
Bank borrowings and overdrafts
|
$ | 37,872 | $ | 76,780 | ||||||||||||
|
Current portion of long-term debt
|
5.96 | % | 100,000 | | ||||||||||||
|
|
||||||||||||||||
|
Total current debt
|
137,872 | 76,780 | ||||||||||||||
|
|
||||||||||||||||
|
Senior notes 2007
|
6.38 | % | 2017-27 | 500,000 | 500,000 | |||||||||||
|
Senior notes 2006
|
6.10 | % | 2012-16 | 225,000 | 325,000 | |||||||||||
|
Bank borrowings
|
0.39 | % | 2012 | 50,380 | 75,166 | |||||||||||
|
Japanese Yen notes
|
2.81 | % | 2011 | 21,886 | 19,614 | |||||||||||
|
Other
|
8 | 16 | ||||||||||||||
|
Deferred realized gains on interest rate swaps
|
13,445 | 14,953 | ||||||||||||||
|
|
||||||||||||||||
|
Total long-term debt
|
810,719 | 934,749 | ||||||||||||||
|
|
||||||||||||||||
|
Total debt
|
$ | 948,591 | $ | 1,011,529 | ||||||||||||
|
|
||||||||||||||||
8
| 2010 | 2009 | |||||||
|
Weighted average fair value of SSARs granted during the period
|
$ | 10.41 | $ | 7.08 | ||||
|
Assumptions:
|
||||||||
|
Risk-free interest rate
|
2.2 | % | 2.5 | % | ||||
|
Expected volatility
|
29.8 | % | 30.9 | % | ||||
|
Expected dividend yield
|
2.2 | % | 3.2 | % | ||||
|
Expected life, in years
|
5 | 5 | ||||||
|
Termination rate
|
1.09 | % | 0.91 | % | ||||
|
Exercise multiple
|
1.38 | 1.46 | ||||||
| Weighted Average | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | Options/SSARs | Exercise Price | ||||||
|
Balance at December 31, 2009
|
2,228 | $ | 35.27 | |||||
|
Exercised
|
(391 | ) | $ | 34.04 | ||||
|
Cancelled
|
(6 | ) | $ | 43.13 | ||||
|
|
||||||||
|
Balance at March 31, 2010
|
1,831 | $ | 35.50 | |||||
|
|
||||||||
|
Granted
|
197 | $ | 44.92 | |||||
|
Exercised
|
(173 | ) | $ | 32.27 | ||||
|
Cancelled
|
(38 | ) | $ | 35.47 | ||||
|
|
||||||||
|
Balance at June 30, 2010
|
1,817 | $ | 36.82 | |||||
|
|
||||||||
|
Exercised
|
(78 | ) | $ | 32.89 | ||||
|
|
||||||||
|
Balance at September 30, 2010
|
1,739 | $ | 37.00 | |||||
|
|
||||||||
9
| Weighted Average | ||||||||
| Grant Date Fair | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | RSU | Value Per Share | ||||||
|
Balance at December 31, 2009
|
978 | $ | 37.42 | |||||
|
Cancelled
|
(2 | ) | $ | 41.16 | ||||
|
|
||||||||
|
Balance at March 31, 2010
|
976 | $ | 38.52 | |||||
|
|
||||||||
|
Granted
|
281 | $ | 45.95 | |||||
|
Vested
|
(193 | ) | $ | 40.30 | ||||
|
Cancelled
|
(12 | ) | $ | 38.15 | ||||
|
|
||||||||
|
Balance at June 30, 2010
|
1,052 | $ | 37.29 | |||||
|
|
||||||||
|
Granted
|
24 | $ | 45.47 | |||||
|
Vested
|
(1 | ) | $ | 36.33 | ||||
|
Cancelled
|
(18 | ) | $ | 37.06 | ||||
|
|
||||||||
|
Balance at September 30, 2010
|
1,057 | $ | 37.49 | |||||
|
|
||||||||
| Weighted Average | ||||||||
| Grant Date Fair | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | PRS | Value Per Share | ||||||
|
Balance at December 31, 2009
|
498 | $ | 20.28 | |||||
|
Granted
|
39 | $ | 22.90 | |||||
|
Cancelled
|
(4 | ) | $ | 15.24 | ||||
|
|
||||||||
|
Balance at March 31, 2010
|
533 | $ | 20.52 | |||||
|
|
||||||||
|
Granted
|
174 | $ | 22.46 | |||||
|
Vested
|
(180 | ) | $ | 25.89 | ||||
|
|
||||||||
|
Balance at June 30, 2010
|
527 | $ | 19.31 | |||||
|
|
||||||||
|
Cancelled
|
(2 | ) | $ | 15.24 | ||||
|
|
||||||||
|
Balance at September 30, 2010
|
525 | $ | 19.32 | |||||
|
|
||||||||
10
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | 2010 | 2009 | ||||||||||||
|
Restricted stock and RSUs
|
$ | 5,530 | $ | 4,404 | $ | 15,639 | $ | 13,228 | ||||||||
|
Stock options and SSARs
|
398 | 525 | 1,069 | 1,837 | ||||||||||||
|
|
||||||||||||||||
|
Total equity
compensation
expense
|
$ | 5,928 | $ | 4,929 | $ | 16,708 | $ | 15,065 | ||||||||
|
|
||||||||||||||||
| Three Months Ended September 30, 2010 | ||||||||||||||||
| Global | ||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | ||||||||||||
|
|
||||||||||||||||
|
Net sales
|
$ | 300,540 | $ | 372,743 | $ | | $ | 673,283 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Operating profit
|
$ | 62,980 | $ | 68,611 | $ | (11,067 | ) | $ | 120,524 | |||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Interest expense
|
(12,244 | ) | ||||||||||||||
|
Other income (expense), net
|
(2,097 | ) | ||||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
$ | 106,183 | ||||||||||||||
|
|
||||||||||||||||
| Three Months Ended September 30, 2009 | ||||||||||||||||
| Global | ||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | ||||||||||||
|
|
||||||||||||||||
|
Net sales
|
$ | 275,421 | $ | 337,213 | $ | | $ | 612,634 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Operating profit
|
$ | 54,981 | $ | 47,268 | $ | (14,486 | ) | $ | 87,763 | |||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Interest expense
|
(13,503 | ) | ||||||||||||||
|
Other income (expense), net
|
24 | |||||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
$ | 74,284 | ||||||||||||||
|
|
||||||||||||||||
11
| Nine Months Ended September 30, 2010 | ||||||||||||||||
| Global | ||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | ||||||||||||
|
|
||||||||||||||||
|
Net sales
|
$ | 905,032 | $ | 1,087,961 | $ | | $ | 1,992,993 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Operating profit
|
$ | 189,064 | $ | 190,000 | $ | (46,169 | ) | $ | 332,895 | |||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Interest expense
|
(37,031 | ) | ||||||||||||||
|
Other income (expense), net
|
(6,967 | ) | ||||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
$ | 288,897 | ||||||||||||||
|
|
||||||||||||||||
| Nine Months Ended September 30, 2009 | ||||||||||||||||
| Global | ||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | ||||||||||||
|
|
||||||||||||||||
|
Net sales
|
$ | 811,310 | $ | 929,215 | $ | | $ | 1,740,525 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Operating profit
|
$ | 162,415 | $ | 121,803 | $ | (31,076 | ) | $ | 253,142 | |||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Interest expense
|
(47,331 | ) | ||||||||||||||
|
Other income (expense), net
|
(383 | ) | ||||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
$ | 205,428 | ||||||||||||||
|
|
||||||||||||||||
12
| U.S. Plans | Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | 2010 | 2009 | ||||||||||||
|
Service cost for benefits earned
|
$ | 1,016 | $ | 700 | $ | 2,836 | $ | 3,060 | ||||||||
|
Interest cost on projected benefit obligation
|
6,164 | 5,794 | 18,143 | 17,764 | ||||||||||||
|
Expected return on plan assets
|
(6,026 | ) | (6,379 | ) | (18,110 | ) | (18,463 | ) | ||||||||
|
Net amortization and deferrals
|
1,958 | 1,641 | 5,581 | 4,809 | ||||||||||||
|
|
||||||||||||||||
|
Defined benefit plans
|
3,112 | 1,756 | 8,450 | 7,170 | ||||||||||||
|
Defined contribution and other retirement
plans
|
1,742 | 1,699 | 5,479 | 5,482 | ||||||||||||
|
|
||||||||||||||||
|
Total pension expense
|
$ | 4,854 | $ | 3,455 | $ | 13,929 | $ | 12,652 | ||||||||
|
|
||||||||||||||||
| Non-U.S. Plans | Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | 2010 | 2009 | ||||||||||||
|
Service cost for benefits earned
|
$ | 2,448 | $ | 2,012 | $ | 7,642 | $ | 6,035 | ||||||||
|
Interest cost on projected benefit obligation
|
8,506 | 7,136 | 25,518 | 21,408 | ||||||||||||
|
Expected return on plan assets
|
(10,710 | ) | (9,351 | ) | (32,149 | ) | (28,052 | ) | ||||||||
|
Net amortization and deferrals
|
1,345 | 697 | 4,034 | 2,092 | ||||||||||||
|
(Gain)/loss due to settlements and curtailments
|
63 | | 126 | | ||||||||||||
|
|
||||||||||||||||
|
Defined benefit plans
|
1,652 | 494 | 5,171 | 1,483 | ||||||||||||
|
Defined contribution and other retirement plans
|
985 | 1,211 | 3,182 | 3,264 | ||||||||||||
|
|
||||||||||||||||
|
Total pension expense
|
$ | 2,637 | $ | 1,705 | $ | 8,353 | $ | 4,747 | ||||||||
|
|
||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| (DOLLARS IN THOUSANDS) | 2010 | 2009 | 2010 | 2009 | ||||||||||||
|
Service cost for benefits earned
|
$ | 410 | $ | 351 | $ | 1,230 | $ | 1,233 | ||||||||
|
Interest on benefit obligation
|
1,643 | 1,513 | 4,929 | 4,625 | ||||||||||||
|
Net amortization and deferrals
|
(489 | ) | (379 | ) | (1,467 | ) | (1,509 | ) | ||||||||
|
|
||||||||||||||||
|
Total postretirement benefit expense
|
$ | 1,564 | $ | 1,485 | $ | 4,692 | $ | 4,349 | ||||||||
|
|
||||||||||||||||
13
| | Level 1-Quoted prices for identical instruments in active markets. |
| | Level 2-Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. |
| | Level 3-Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable . |
14
15
| September 30, 2010 | ||||||||||||
| Fair Value of | Fair Value of | |||||||||||
| Derivatives | Derivatives Not | |||||||||||
| Designated as | Designated as | |||||||||||
| Hedging | Hedging | Total Fair | ||||||||||
| Instruments | Instruments | Value | ||||||||||
|
|
||||||||||||
|
Derivative assets (a)
|
||||||||||||
|
Foreign currency contracts
|
$ | | $ | 1.7 | $ | 1.7 | ||||||
|
Interest rate swaps
|
$ | 0.4 | $ | | $ | 0.4 | ||||||
|
|
||||||||||||
|
|
$ | 0.4 | $ | 1.7 | $ | 2.1 | ||||||
|
|
||||||||||||
|
Derivative liabilities (b)
|
||||||||||||
|
Foreign currency contracts
|
$ | 23.1 | $ | 3.7 | $ | 26.8 | ||||||
| December 31, 2009 | ||||||||||||
| Fair Value of | Fair Value of | |||||||||||
| Derivatives | Derivatives Not | |||||||||||
| Designated as | Designated as | |||||||||||
| Hedging | Hedging | Total Fair | ||||||||||
| Instruments | Instruments | Value | ||||||||||
|
|
||||||||||||
|
Derivative assets (a)
|
||||||||||||
|
Foreign currency contracts
|
$ | | $ | 0.2 | $ | 0.2 | ||||||
|
Interest rate swap
|
$ | 0.2 | $ | | $ | 0.2 | ||||||
|
|
||||||||||||
|
|
$ | 0.2 | $ | 0.2 | $ | 0.4 | ||||||
|
|
||||||||||||
|
Derivative liabilities (b)
|
||||||||||||
|
Foreign currency contracts
|
$ | 4.5 | $ | 0.9 | $ | 5.4 | ||||||
| (a) | Derivative assets are recorded to Prepaid expenses and other current assets in the Consolidated Balance Sheet. | |
| (b) | All derivative liabilities are recorded as Other current liabilities in the Consolidated Balance Sheet. |
16
| Amount of Gain or (Loss) | ||||||||||
| Recognized in Income on | Location of Gain | |||||||||
| Derivative | or (Loss) | |||||||||
| Derivatives Not Designated as | For the three months | Recognized in | ||||||||
| Hedging Instruments under | ended September 30, | Income on | ||||||||
| ASC 815 | 2010 | 2009 | Derivative | |||||||
|
|
||||||||||
|
Foreign currency contract
|
$ | (7.2 | ) | $ | (11.0 | ) | Other (income) expense, net | |||
| Amount of Gain or (Loss) | ||||||||||
| Recognized in Income on | Location of Gain | |||||||||
| Derivative | or (Loss) | |||||||||
| Derivatives Not Designated as | For the nine months | Recognized in | ||||||||
| Hedging Instruments under | ended September 30, | Income on | ||||||||
| ASC 815 | 2010 | 2009 | Derivative | |||||||
|
|
||||||||||
|
Foreign currency contract
|
$ | 7.2 | $ | (3.8 | ) | Other (income) expense, net | ||||
17
| Amount of Gain or | ||||||||||||||||||||
| Amount of Gain or | (Loss) Reclassified | |||||||||||||||||||
| (Loss) Recognized in | from Accumulated | |||||||||||||||||||
| OCI on Derivative | Location of Gain or | OCI into Income | ||||||||||||||||||
| (Effective Portion) | (Loss) Reclassified | (Effective Portion) | ||||||||||||||||||
| For the three months | from Accumulated | For the three months | ||||||||||||||||||
| ended September 30, | OCI into Income | ended September 30, | ||||||||||||||||||
| 2010 | 2009 | (Effective Portion) | 2010 | 2009 | ||||||||||||||||
|
|
||||||||||||||||||||
|
Derivatives in Cash Flow
Hedging Relationships:
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Cross currency swap (1)
|
$ | (0.4 | ) | $ | (0.9 | ) | Other (income) expense, net | $ | (0.5 | ) | $ | (0.2 | ) | |||||||
|
Forward currency contract
|
$ | (5.5 | ) | $ | | Cost of goods sold | $ | | $ | | ||||||||||
|
|
||||||||||||||||||||
|
Derivatives in Net Investment
Hedging Relationships:
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Forward currency contract
|
$ | (9.3 | ) | $ | | N/A | $ | | $ | | ||||||||||
|
|
||||||||||||||||||||
|
Total
|
$ | (15.2 | ) | $ | (0.9 | ) | $ | (0.5 | ) | $ | (0.2 | ) | ||||||||
|
|
||||||||||||||||||||
| Amount of Gain or | ||||||||||||||||||||
| Amount of Gain or | (Loss) Reclassified | |||||||||||||||||||
| (Loss) Recognized in | from Accumulated | |||||||||||||||||||
| OCI on Derivative | Location of Gain or | OCI into Income | ||||||||||||||||||
| (Effective Portion) | (Loss) Reclassified | (Effective Portion) | ||||||||||||||||||
| For the nine months | from Accumulated | For the nine months | ||||||||||||||||||
| ended September 30, | OCI into Income | ended September 30, | ||||||||||||||||||
| 2010 | 2009 | (Effective Portion) | 2010 | 2009 | ||||||||||||||||
|
|
||||||||||||||||||||
|
Derivatives in Cash Flow
Hedging Relationships:
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Cross currency swap (1)
|
$ | (0.6 | ) | $ | 0.3 | Other (income) expense, net | $ | (1.1 | ) | $ | (0.5 | ) | ||||||||
|
Forward currency contract
|
$ | (4.7 | ) | $ | | Cost of goods sold | $ | | $ | | ||||||||||
|
|
||||||||||||||||||||
|
Derivatives in Net Investment
Hedging Relationships:
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Forward currency contract
|
$ | (6.2 | ) | $ | | N/A | $ | | $ | | ||||||||||
|
|
||||||||||||||||||||
|
Total
|
$ | (11.5 | ) | $ | 0.3 | $ | (1.1 | ) | $ | (0.5 | ) | |||||||||
|
|
||||||||||||||||||||
| (1) | Ten year swap executed in 2003 |
18
19
20
| | created for the exclusive use by a specific customer; |
| | sold in powder or liquid form, in amounts ranging from a few pounds to several tons, depending on the nature of the end product in which they are used; |
| | a small percentage of the volume and cost of the end product sold to the consumer; and |
| | a major factor in directing consumer preference for consumer packaged goods. |
21
| % Change in Sales-Third Quarter 2010 vs Third Quarter 2009 | ||||||||||||||||||||||||||
| Fine & | ||||||||||||||||||||||||||
| Beauty Care | Functional | Ingredients | Total Frag. | Flavors | Total | |||||||||||||||||||||
|
North America
|
Reported | 6 | % | 0 | % | 33 | % | 11 | % | 9 | % | 10 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
EAME
|
Reported | 11 | % | -2 | % | 0 | % | 3 | % | 4 | % | 3 | % | |||||||||||||
|
|
Local Currency | 23 | % | 7 | % | 9 | % | 13 | % | 13 | % | 13 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Latin America
|
Reported | 55 | % | 8 | % | 11 | % | 25 | % | 8 | % | 19 | % | |||||||||||||
|
|
Local Currency | 54 | % | 8 | % | 12 | % | 25 | % | 7 | % | 18 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Greater Asia
|
Reported | 27 | % | 8 | % | 15 | % | 14 | % | 14 | % | 14 | % | |||||||||||||
|
|
Local Currency | 26 | % | 7 | % | 13 | % | 13 | % | 11 | % | 12 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Total
|
Reported | 20 | % | 3 | % | 12 | % | 11 | % | 9 | % | 10 | % | |||||||||||||
|
|
Local Currency | 24 | % | 6 | % | 18 | % | 15 | % | 10 | % | 13 | % | |||||||||||||
| | North America Fine & Beauty Care sales growth was driven entirely by new business wins with our customers. The strong performance in Ingredients reflects broad-based volume gains including re-stocking impacts and weak market conditions last year. Functional Fragrance sales were essentially flat versus last year as new business wins in all categories offset volume erosion. The Flavors business was led by growth in the Beverage and Confectionary categories. |
| | EAME showed solid sales gains across all categories, led by new wins in Fine Fragrance, Hair Care and Fabric, double-digit growth in Beverage and Dairy, plus additional volume gains in Ingredients. |
22
| | Latin America sales performance was driven by more than 50% growth in Fine & Beauty Care (reflecting both net new wins and good growth in our customers business), solid growth in Functional plus demand recovery in Ingredients. Flavors growth was led by continued gains within our Confectionery and Savory categories. |
| | Greater Asia delivered double-digit LC sales growth in all categories except Functional Fragrance (which experienced exceptionally strong growth in the year-ago period). New business wins, primarily in Fabric and Personal Wash were partially offset by isolated erosion in Fabric. Our Flavor business continues to deliver strong sales growth driven by gains with both global and local accounts in key growth markets. The improvement was strongest within the Beverage and Confectionary categories. |
| Three months ended | ||||||||
| September 30, | ||||||||
| 2010 | 2009 | |||||||
|
Cost of goods sold
|
57.7 | % | 59.4 | % | ||||
|
Research and development expenses
|
7.9 | % | 8.1 | % | ||||
|
Selling and administrative expenses
|
16.2 | % | 16.5 | % | ||||
23
24
| % Change in Sales- Nine Months 2010 vs 2009 | ||||||||||||||||||||||||||
| Fine & | ||||||||||||||||||||||||||
| Beauty Care | Functional | Ingredients | Total Frag. | Flavors | Total | |||||||||||||||||||||
|
North America
|
Reported | 16 | % | 3 | % | 27 | % | 14 | % | 5 | % | 9 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
EAME
|
Reported | 30 | % | 5 | % | 17 | % | 16 | % | 12 | % | 15 | % | |||||||||||||
|
|
Local Currency | 35 | % | 8 | % | 22 | % | 21 | % | 14 | % | 18 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Latin America
|
Reported | 42 | % | 7 | % | 15 | % | 21 | % | 10 | % | 17 | % | |||||||||||||
|
|
Local Currency | 38 | % | 7 | % | 16 | % | 19 | % | 6 | % | 14 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Greater Asia
|
Reported | 25 | % | 21 | % | 11 | % | 20 | % | 18 | % | 19 | % | |||||||||||||
|
|
Local Currency | 23 | % | 19 | % | 10 | % | 18 | % | 12 | % | 15 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Total
|
Reported | 28 | % | 9 | % | 19 | % | 17 | % | 12 | % | 15 | % | |||||||||||||
|
|
Local Currency | 29 | % | 9 | % | 21 | % | 18 | % | 10 | % | 14 | % | |||||||||||||
| | North America Fine & Beauty sales growth was driven by volume growth in Fine Fragrance associated with general demand recovery (including some elements of re-stocking) as well as weaker year ago comparison levels (mostly in the first half of the year) combined with good market success for new business wins. The strong performance in Ingredients reflects broad-based volume gains, re-stocking and weak market conditions last year. Functional Fragrance sales increased as good win performance across all segments more than offset sales erosion in Fabric and Home Care. The net gain was strongest within the Personal Wash segment. Beverages sales led the growth in the Flavors business, followed by Confectionery and Savory. |
| | EAME delivered strong sales gains across all categories, led by net new business wins and demand recovery in Fine Fragrance, Ingredients and Fabric plus higher volume and new wins for Flavors, notably within the Beverage category. Re-stocking also supported growth across most categories. |
| | Latin America sales performance was driven by a general recovery in demand and new business wins in Fine & Beauty, Confectionery and Savory categories that more than offset the effect of non-strategic business lost last year. The Functional Fragrance category improvement benefited from both new business wins and volume recovery in Fabric Care and Home Care. |
| | GA delivered double-digit LC sales growth in all categories, except Ingredients. Fine & Beauty Care gains were driven by new business wins and demand recovery in Hair Care and Toiletries. Fine Fragrance also benefited from demand recovery and a weaker prior year base. Within Functional Fragrances, Fabric, Home Care and Personal Wash all achieved double-digit gains reflecting both strong commercial performance and solid demand growth. Flavor sales growth was driven by new product introductions and volume growth mainly in Savory and Beverage, with all categories producing double-digit gains. |
25
| Nine months ended | ||||||||
| September 30, | ||||||||
| 2010 | 2009 | |||||||
|
Cost of goods sold
|
57.8 | % | 59.8 | % | ||||
|
Research and development expenses
|
8.1 | % | 8.1 | % | ||||
|
Selling and administrative expenses
|
16.9 | % | 16.7 | % | ||||
26
| Restructuring Charges | ||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| (In Thousands) | 2010 | 2009 | 2010 | 2009 | ||||||||||||
|
Flavors
|
$ | | $ | | $ | | $ | (363 | ) | |||||||
|
Fragrances
|
2,355 | 10,500 | 9,186 | 15,349 | ||||||||||||
|
Global
|
| | | (382 | ) | |||||||||||
|
|
||||||||||||||||
|
Total
|
$ | 2,355 | $ | 10,500 | $ | 9,186 | $ | 14,604 | ||||||||
|
|
||||||||||||||||
27
28
| 12 Months Ended September 30, | ||||||||
| (In Millions) | 2010 | 2009 | ||||||
|
Net income
|
$ | 255.4 | $ | 197.1 | ||||
|
Interest expense
|
51.5 | 66.5 | ||||||
|
Income taxes
|
104.6 | 48.0 | ||||||
|
Depreciation
|
74.5 | 67.9 | ||||||
|
Amortization
|
6.1 | 6.2 | ||||||
|
Specified items
(1)
|
12.9 | 35.0 | ||||||
|
|
||||||||
|
Adjusted EBITDA
|
$ | 505.0 | $ | 420.7 | ||||
|
|
||||||||
| (1) | Specified items for the 12 months ended September 30, 2010 of $12.9 million consist of restructuring charges. Specified items for the 12 months ended September 30, 2009 of $35 million consist principally of restructuring charges ($28.6 million) and employee separation costs ($6.3 million). |
| September 30, | ||||||||
| (In Millions) | 2010 | 2009 | ||||||
|
Total debt
|
$ | 948.6 | $ | 1,157.6 | ||||
|
Adjustments:
|
||||||||
|
Deferred gain on interest rate swaps
|
(13.4 | ) | (15.4 | ) | ||||
|
Cash and cash equivalents
|
(114.9 | ) | (154.6 | ) | ||||
|
|
||||||||
|
Net debt
|
$ | 820.3 | $ | 987.6 | ||||
|
|
||||||||
29
30
31
32
| Total Number of | ||||||||||||||||
| Total | Shares Purchased | Maximum Number | ||||||||||||||
| Number of | Average | as Part of Publicly | of Shares That May | |||||||||||||
| Shares | Price Paid | Announced | Yet Be Purchased | |||||||||||||
| Purchased | per Share | Program | Under the Program | |||||||||||||
|
July 1 - 31, 2010
|
| | | | ||||||||||||
|
August 1 - 31, 2010
|
| | | | ||||||||||||
|
September 1 - 30, 2010
|
| | | | ||||||||||||
|
Total shares purchased
|
| | | | ||||||||||||
33
| 31.1 |
Certification of Douglas D. Tough pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 31.2 |
Certification of Kevin C. Berryman pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 32 |
Certification of Douglas D. Tough and Kevin C. Berryman pursuant to
18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act
of 2002.
|
| Dated: November 4, 2010 | By: | /s/ Douglas D. Tough | ||
| Douglas D. Tough | ||||
| Chairman of the Board and Chief Executive Officer | ||||
| Dated: November 4, 2010 | By: | /s/ Kevin C. Berryman | ||
| Kevin C. Berryman | ||||
| Executive Vice President and Chief Financial Officer | ||||
34
| Number | Description | |||
|
|
||||
| 31.1 |
Certification of Douglas D. Tough pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 31.2 |
Certification of Kevin C. Berryman pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 32 |
Certification of Douglas D. Tough and Kevin C. Berryman pursuant to
18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act
of 2002.
|
|||
35
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| The Estée Lauder Companies Inc. | EL |
| L Brands, Inc. | LB |
| Revlon, Inc. | REV |
Suppliers
| Supplier name | Ticker |
|---|---|
| Stepan Company | SCL |
| Sensient Technologies Corporation | SXT |
| Tredegar Corporation | TG |
| Flotek Industries, Inc. | FTK |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|